Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortProteasome inhibitor injection for multiple myeloma.Oral immunomodulatory drug for myeloma; strict pregnancy-prevention programme.
Body systemCancerCancer
Drug classMyeloma agentsMyeloma agents
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesMultiple myeloma, Mantle cell lymphomaMultiple myeloma, Myelodysplastic syndromes with 5q deletion, Some lymphomas
How it worksDisrupts protein recycling in myeloma cells.Boosts immune attack on myeloma cells.
Starts workingDepends on the cancer and regimenDepends on the cancer and regimen
Half-life40–193 hoursAbout 3 hours
Typical adult doseDosed by your cancer team according to the treatment protocol.Dosed by your cancer team according to the treatment protocol.
FormsSubcutaneous injection, IV injectionCapsule
Common side effectsTingling and numbness, Low platelets, Nausea, Diarrhoea, TirednessTiredness, Low blood counts, Diarrhoea, Constipation, Muscle cramps, Rash
Serious side effectsPainful nerve damage, Low blood pressure, Shingles reactivationBlood clots, Severe neutropenia, Birth defects, Second cancers
Don't take ifPregnancy; Intrathecal administration (fatal)Pregnancy; Women able to become pregnant without contraception; Severe kidney impairment without dose reduction
AlcoholBest to limit. Alcohol can worsen dizziness.Best to limit. Alcohol can add to tiredness.
PregnancyUsually avoidedAvoid.Usually avoidedCauses severe birth defects. A pregnancy-prevention programme applies.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: VelcadeUnited Kingdom: VelcadeIndia: Velcade, Bortenat, Bortezomib (generic)United States: RevlimidUnited Kingdom: RevlimidIndia: Revlimid, Lenalid, Lenalidomide (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL01XG01L04AX04

Taken together

  • ModerateBortezomib + Lenalidomide: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker